Onyx Biotec bulk deals and insider trading
NSE: ONYXPharmaceuticals & Biotechnology
Onyx Biotec Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2024 · Issue price ₹61
Last close ₹36.00down ₹0.50 (1.37%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹36.50.
28 Oct: open ₹36.00, high ₹36.00, low ₹36.00
52-week range of traded prices to 28 Oct 2026
₹24.20Low, 22 May 2026₹49.65High, 5 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹65 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,000100.0% delivered
Onyx Biotec's insiders have 4 trade disclosures on record, the latest on 24 Jun 2026. Its promoter group made no purchase or sale on the market in the 12 months to 28 Oct 2026.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Onyx Biotec promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Onyx Biotec insider trading
Jun 2026
- SANJAY JAIN₹3.41 Cr10,00,000 sharesSold or invoked · Promoter And Designated Person · 19 Jun 2026 · disclosed 24 Jun
- FATEH PAL SINGH₹4.70 Cr13,40,000 sharesSold or invoked · Promoter · 19 Jun 2026 · disclosed 24 Jun
- FATEH PAL SINGH₹0.44 Cr1,24,000 sharesSold or invoked · Promoter · 18 Jun 2026 · disclosed 24 Jun
May 2026
- SANJAY JAIN₹5.44 Cr17,74,000 sharesSold or invoked · Promoter And Designated Person · 27 May 2026 · disclosed 1 Jun
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Onyx Biotec bulk deals
Last 12 months, since 30 Oct 2025: 17 bulk deals, ₹15 Cr bought and ₹17 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 16 Sep 20261 firm · ₹0.46 Cr bought · ₹0 soldNet bought ₹0.46 Cr
- BoughtTUSHAR KINKERBought 1,22,000 at ₹38.000.67% of the company₹0.46 Cr
Thursday 30 Jul 20262 firms · ₹0.65 Cr bought · ₹0.53 Cr soldNet bought ₹0.12 Cr
- BoughtMONIKA U. SHAHBought 1,44,000 at ₹44.900.79% of the company₹0.65 Cr
- SoldPROGNOSIS SECURITIES PVT. LTDSold 1,18,000 at ₹44.900.65% of the company₹0.53 Cr
Monday 29 Jun 20261 firm · ₹0 bought · ₹0.87 Cr soldNet sold ₹0.87 Cr
- SoldNEHA BAGLASold 2,24,000 at ₹38.901.24% of the company₹0.87 Cr
Tuesday 23 Jun 20261 firm · ₹0 bought · ₹0.46 Cr soldNet sold ₹0.46 Cr
- SoldNEHA BAGLASold 1,12,000 at ₹40.950.62% of the company₹0.46 Cr
Friday 19 Jun 20265 firms · ₹7.34 Cr bought · ₹8.11 Cr soldNet sold ₹0.78 Cr
- SoldFATEH PAL SINGHSold 13,40,000 at ₹35.107.39% of the company₹4.70 Cr
- BoughtKUNAL BHARDWAJBought 10,00,000 at ₹34.105.52% of the company₹3.41 Cr
- SoldSANJAY JAINSold 10,00,000 at ₹34.105.52% of the company₹3.41 Cr
- BoughtKANHAIYA BHARDWAJBought 6,82,000 at ₹35.003.76% of the company₹2.39 Cr
- BoughtGAUTAM BHARDWAJBought 4,40,000 at ₹35.002.43% of the company₹1.54 Cr
Thursday 18 Jun 20261 firm · ₹0 bought · ₹0.44 Cr soldNet sold ₹0.44 Cr
- SoldFATEH PAL SINGHSold 1,24,000 at ₹35.400.68% of the company₹0.44 Cr
Wednesday 27 May 20262 firms · ₹5.27 Cr bought · ₹5.44 Cr soldNet sold ₹0.16 Cr
- SoldSANJAY JAINSold 17,74,000 at ₹30.649.78% of the company₹5.44 Cr
- BoughtKUNAL BHARDWAJBought 17,22,000 at ₹30.639.50% of the company₹5.27 Cr
Monday 30 Mar 20263 firms · ₹1.12 Cr bought · ₹1.10 Cr soldNet bought ₹0.02 Cr
- BoughtNEHA BAGLABought 3,50,000 at ₹32.051.93% of the company₹1.12 Cr
- SoldGLOBALWORTH SECURITIES LIMITEDSold 1,90,000 at ₹32.001.05% of the company₹0.61 Cr
- SoldZETA GLOBAL FUNDS (OEIC) PCC LIMITED - ZETA SERIES C FUND PCSold 1,54,000 at ₹32.000.85% of the company₹0.49 Cr
Tuesday 24 Mar 20262 firms · ₹0.44 Cr bought · ₹0.44 Cr soldNet nil
- BoughtDEEPAK BAID (HUF)Bought 1,50,000 at ₹29.130.83% of the company₹0.44 Cr
- SoldDEEPAK BAIDSold 1,50,000 at ₹29.100.83% of the company₹0.44 Cr
Thursday 18 Sep 20251 firm · ₹0 bought · ₹1.69 Cr soldNet sold ₹1.69 Cr
- SoldZETA GLOBAL FUNDS (OEIC) PCC LIMITED-ZETA SERIES B FUND PCSold 3,74,000 at ₹45.122.06% of the company₹1.69 Cr
Tuesday 16 Sep 20252 firms · ₹0.49 Cr bought · ₹0.51 Cr soldNet sold ₹0.02 Cr
- SoldGLOBALWORTH SECURITIES LIMITEDSold 1,04,000 at ₹49.000.57% of the company₹0.51 Cr
- BoughtPROGNOSIS SECURITIES PVT. LTDBought 1,00,000 at ₹49.000.55% of the company₹0.49 Cr
Monday 8 Sep 20251 firm · ₹0.49 Cr bought · ₹0 soldNet bought ₹0.49 Cr
- BoughtPROGNOSIS SECURITIES PVT. LTDBought 1,00,000 at ₹49.000.55% of the company₹0.49 Cr
Monday 11 Aug 20251 firm · ₹0 bought · ₹0.90 Cr soldNet sold ₹0.90 Cr
- SoldGLOBALWORTH SECURITIES LIMITEDSold 1,76,000 at ₹51.030.97% of the company₹0.90 Cr
Friday 8 Aug 20252 firms · ₹0.47 Cr bought · ₹0.95 Cr soldNet sold ₹0.48 Cr
- SoldMARWADI SHARES AND FINANCE LTD.Sold 1,86,000 at ₹50.011.03% of the company₹0.93 Cr
- Both waysINCREMENTUM CAPITAL ADVISORS LLPBought 94,000 at ₹50.00Sold 4,000 at ₹48.800.52% of the companyNet +90,000 shares₹0.47 Cr bought
Thursday 7 Aug 20251 firm · ₹0 bought · ₹0.49 Cr soldNet sold ₹0.49 Cr
- SoldMARWADI SHARES AND FINANCE LTD.Sold 1,00,000 at ₹49.000.55% of the company₹0.49 Cr
Tuesday 29 Apr 20251 firm · ₹0 bought · ₹1.40 Cr soldNet sold ₹1.40 Cr
- SoldACINTYO INVESTMENT FUND PCC- CELL 1Sold 2,64,000 at ₹53.191.46% of the company₹1.40 Cr
Thursday 24 Apr 20251 firm · ₹0.49 Cr bought · ₹0 soldNet bought ₹0.49 Cr
- BoughtZETA GLOBAL FUNDS (OEIC) PCC LIMITED-ZETA SERIES B FUND PCBought 98,000 at ₹49.950.54% of the company₹0.49 Cr
Friday 11 Apr 20252 firms · ₹0.50 Cr bought · ₹0.56 Cr soldNet sold ₹0.06 Cr
- SoldACINTYO INVESTMENT FUND PCC- CELL 1Sold 1,12,000 at ₹50.030.62% of the company₹0.56 Cr
- BoughtPROGNOSIS SECURITIES PVT. LTDBought 1,00,000 at ₹50.000.55% of the company₹0.50 Cr
Friday 21 Mar 20253 firms · ₹1.83 Cr bought · ₹1.56 Cr soldNet bought ₹0.27 Cr
- SoldACINTYO INVESTMENT FUND PCC- CELL 1Sold 2,56,000 at ₹61.001.41% of the company₹1.56 Cr
- BoughtKADAYAM RAMANATHAN BHARATBought 2,00,000 at ₹60.931.10% of the company₹1.22 Cr
- BoughtSURESH KANODIABought 1,00,000 at ₹61.000.55% of the company₹0.61 Cr
Wednesday 19 Mar 20252 firms · ₹0.61 Cr bought · ₹0.60 Cr soldNet bought ₹0.01 Cr
- BoughtJOSHIAH JEYAKUMARBought 1,00,000 at ₹60.950.55% of the company₹0.61 Cr
- SoldACINTYO INVESTMENT FUND PCC- CELL 1Sold 98,000 at ₹60.950.54% of the company₹0.60 Cr
Wednesday 8 Jan 20251 firm · ₹0 bought · ₹0.83 Cr soldNet sold ₹0.83 Cr
- SoldATUL KHEMKASold 1,00,000 at ₹82.650.55% of the company₹0.83 Cr
Thursday 2 Jan 20251 firm · ₹0.86 Cr bought · ₹0 soldNet bought ₹0.86 Cr
- BoughtMARWADI SHARES AND FINANCE LTD.Bought 92,000 at ₹93.240.51% of the company₹0.86 Cr
Tuesday 31 Dec 20243 firms · ₹5.25 Cr bought · ₹1.44 Cr soldNet bought ₹3.81 Cr
- Both waysGLOBALWORTH SECURITIES LIMITEDBought 3,06,000 at ₹87.51Sold 2,000 at ₹89.801.69% of the companyNet +3,04,000 shares₹2.68 Cr bought
- BoughtMARWADI SHARES AND FINANCE LTD.Bought 1,42,000 at ₹85.210.78% of the company₹1.21 Cr
- Both waysPROGNOSIS SECURITIES PVT. LTDBought 1,68,000 at ₹81.29Sold 1,68,000 at ₹84.580.93% of the companyNet nil₹1.37 Cr bought
Monday 30 Dec 20242 firms · ₹1.85 Cr bought · ₹0 soldNet bought ₹1.85 Cr
- BoughtACINTYO INVESTMENT FUND PCC- CELL 1Bought 1,44,000 at ₹77.050.79% of the company₹1.11 Cr
- BoughtSHOORA RESOURCE PRIVATE LIMITEDBought 1,00,000 at ₹73.970.55% of the company₹0.74 Cr
Friday 27 Dec 20241 firm · ₹0.72 Cr bought · ₹0 soldNet bought ₹0.72 Cr
- BoughtATUL KHEMKABought 1,00,000 at ₹71.650.55% of the company₹0.72 Cr
Thursday 26 Dec 20244 firms · ₹2.63 Cr bought · ₹3.07 Cr soldNet sold ₹0.44 Cr
- SoldPROGNOSIS SECURITIES PVT. LTDSold 2,00,000 at ₹64.651.10% of the company₹1.29 Cr
- Both waysAPNEET KAHLONBought 1,00,000 at ₹62.82Sold 12,000 at ₹64.630.55% of the companyNet +88,000 shares₹0.63 Cr bought
- Both waysLIESHA CORPORATION PRIVATE LIMITED .Bought 2,16,000 at ₹64.65Sold 1,72,000 at ₹64.411.19% of the companyNet +44,000 shares₹1.40 Cr bought
- Both waysHI GROWTH CORPORATE SERVICES PVT LTDBought 98,000 at ₹61.77Sold 98,000 at ₹60.280.54% of the companyNet nil₹0.61 Cr bought
Wednesday 4 Dec 20242 firms · ₹0.92 Cr bought · ₹0.85 Cr soldNet bought ₹0.06 Cr
- BoughtPROGNOSIS SECURITIES PVT. LTDBought 1,50,000 at ₹61.000.83% of the company₹0.92 Cr
- SoldGIRIRAJ STOCK BROKING PRIVATE LIMITEDSold 1,40,000 at ₹61.000.77% of the company₹0.85 Cr
Wednesday 27 Nov 20241 firm · ₹0.67 Cr bought · ₹0 soldNet bought ₹0.67 Cr
- BoughtPROGNOSIS SECURITIES PVT. LTDBought 1,20,000 at ₹56.000.66% of the company₹0.67 Cr
Tuesday 26 Nov 20241 firm · ₹0 bought · ₹1.25 Cr soldNet sold ₹1.25 Cr
- SoldKANODIA STOCK BROKING PVT.LTD.Sold 2,00,000 at ₹62.501.10% of the company₹1.25 Cr
Friday 22 Nov 20243 firms · ₹1.08 Cr bought · ₹1.08 Cr soldNet nil
- BoughtKANODIA STOCK BROKING PVT.LTD.Bought 2,00,000 at ₹54.05₹1.08 Cr
- SoldCRAFT EMERGING MARKET FUND PCC-PROSPERITY INVESTMENTS FUNDSold 1,00,000 at ₹54.05₹0.54 Cr
- SoldSTCI PRIMARY DEALER LIMITEDSold 1,00,000 at ₹54.05₹0.54 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 59 deals on record since listing on 22 Nov 2024.